share_log

欧康维视生物-B(01477.HK)将于8月12日召开董事会会议以审批中期业绩

Ocumension Therapeutics (01477.HK) will hold a board of directors meeting on August 12 to approve its interim performance.

Gelonghui Finance ·  Jul 30 09:52

On July 30th, Gelonhui announced that Eucon Biotechnology-B (01477.HK) will hold a board of directors meeting on August 12, 2024 (Monday) to consider and approve the company's and its affiliates' performance for the mid-term period ending on June 30, 2024, and to consider recommending the payment of interim dividends (if any).

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment